Amarin Corp PLC (NAS:AMRN)
$ 0.704 -0.0208 (-2.93%) Market Cap: 289.25 Mil Enterprise Value: -10.54 Mil PE Ratio: 0 PB Ratio: 0.53 GF Score: 43/100

Amarin Corporation PLC Acc.21 From Bench to Bedside and Beyond - Corporate Call Transcript

May 17, 2021 / 08:30PM GMT
Release Date Price: $4.32 (-1.37%)
Operator

Welcome to Amarin Corporation's American College of Cardiology's 70th Annual Scientific session discussion where select scientific publications presented over the weekend will be discussed. This conference call is being recorded today, May 17, 2021. I would now turn the conference call over to Alina Kolomeyer, Director of Communications at Amarin.

Alina Kolomeyer
Amarin Corporation plc - Director of Communications

Welcome to today's discussion with several distinguished invited guests to explore with our investment community the several important new data sets and analyses related to VASCEPA and REDUCE-IT presented to the medical community at the American College of Cardiology's 70th Annual Scientific session. We are honored today to be able to bring to you for your consideration, the opinions of an esteemed group of clinicians and scientists. Opinions expressed by the clinicians and scientists on this webcast are theirs alone. They have neither been scripted nor previewed by Amarin. While Amarin values their perspective, we may not necessarily agree with their

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot